Rhumbline Advisers Spring Works Therapeutics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 99,653 shares of SWTX stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,653

Previous 104,656 4.78%

Holding current value

$3.62 Million

Previous $3.94 Million 19.03%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$32.04 - $42.76 $160,296 - $213,928	-5,003 Reduced 4.78%	99,653 $3.19 Million
Q2 2024 Aug 01, 2024	BUY	$36.06 - $47.62 $183,220 - $241,957	5,081 Added 5.1%	104,656 $3.94 Million
Q1 2024 May 09, 2024	BUY	$36.5 - $52.5 $164,651 - $236,827	4,511 Added 4.75%	99,575 $4.9 Million
Q4 2023 Feb 08, 2024	BUY	$18.94 - $37.24 $164,247 - $322,945	8,672 Added 10.04%	95,064 $3.47 Million
Q3 2023 Nov 09, 2023	BUY	$23.12 - $31.38 $146,696 - $199,106	6,345 Added 7.93%	86,392 $2 Million
Q2 2023 Aug 08, 2023	BUY	$23.15 - $32.71 $510,596 - $721,451	22,056 Added 38.03%	80,047 $2.1 Million
Q1 2023 May 11, 2023	SELL	$24.97 - $34.05 $1,548 - $2,111	-62 Reduced 0.11%	57,991 $1.49 Million
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $107,324 - $141,848	4,939 Added 9.3%	58,053 $1.51 Million
Q3 2022 Nov 10, 2022	BUY	$24.1 - $39.66 $114,547 - $188,503	4,753 Added 9.83%	53,114 $1.52 Million
Q2 2022 Aug 11, 2022	BUY	$18.36 - $60.07 $325,559 - $1.07 Million	17,732 Added 57.89%	48,361 $1.19 Million
Q1 2022 May 12, 2022	BUY	$48.97 - $65.46 $53,915 - $72,071	1,101 Added 3.73%	30,629 $1.73 Million
Q4 2021 Feb 10, 2022	BUY	$53.3 - $75.84 $7,462 - $10,617	140 Added 0.48%	29,528 $1.83 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $58,148 - $81,905	928 Added 3.26%	29,388 $1.86 Million
Q2 2021 Aug 05, 2021	BUY	$67.45 - $85.63 $161,745 - $205,340	2,398 Added 9.2%	28,460 $2.35 Million
Q1 2021 May 06, 2021	SELL	$65.1 - $93.59 $115,552 - $166,122	-1,775 Reduced 6.38%	26,062 $1.92 Million
Q4 2020 Feb 10, 2021	BUY	$48.36 - $77.92 $175,595 - $282,927	3,631 Added 15.0%	27,837 $2.02 Million
Q3 2020 Nov 12, 2020	SELL	$36.14 - $51.99 $124,249 - $178,741	-3,438 Reduced 12.44%	24,206 $1.15 Million
Q2 2020 Aug 13, 2020	BUY	$22.98 - $48.57 $353,708 - $747,589	15,392 Added 125.63%	27,644 $1.16 Million
Q1 2020 May 06, 2020	BUY	$20.44 - $41.21 $57,763 - $116,459	2,826 Added 29.98%	12,252 $331,000
Q4 2019 Feb 05, 2020	BUY	$17.74 - $39.52 $167,217 - $372,515	9,426 New	9,426 $363,000

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.27B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Spring Works Therapeutics, Inc. Transaction History